https://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/eu-chmp-opinions-and-maa-updates-6PEPZGA2UJGQ5AYWF2FREXETJU/2026-04-28T23:00:11.455Zalways0.5Insightsen2026-04-28T23:00:11.455Zhttps://insights.citeline.com/resizer/7mSlQd4bF5ROaCRmSVn02i6kadA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DS7OSF4SONNZXJB45MR5SXR7ZA.jpghttps://insights.citeline.com/pink-sheet/geography/europe/united-kingdom/uk-must-tackle-variation-in-clinical-trial-set-up-times-says-oshaughnessy-OYMVLVGFYFG6PF52KP5Q45XVK4/2026-04-28T22:59:57.651Zalways0.5Insightsen2026-04-28T22:59:57.651Zhttps://insights.citeline.com/resizer/twckpXvvqV-WBPW3PkrTIQdG1do=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NRG7R6XZ6JEZTJRROWOB6NPLPM.jpghttps://insights.citeline.com/pink-sheet/product-reviews/us-advisory-committees/us-fdas-deep-skepticism-of-azs-novel-camizestrant-trial-design-signals-adcomm-trouble-CBIGSUS6YBC2NEVTJYZ6ZZ3RD4/2026-04-28T22:59:38.784Zalways0.5Insightsen2026-04-28T22:59:38.784Zhttps://insights.citeline.com/resizer/-N4j8_nLYQwCDN1Cjq00myreMMk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/V3NJVEAQGVEI3CHDFQ4MMI5PEM.jpghttps://insights.citeline.com/pink-sheet/product-reviews/post-marketing-regulation-and-studies/us-fda-details-data-manipulation-false-statements-in-tavneos-withdrawal-request-EQKNETMF25DLPOOPWUBAU7XJYA/2026-04-28T22:59:07.15Zalways0.5Insightsen2026-04-28T22:59:07.15Zhttps://insights.citeline.com/resizer/AV-KNZ5m3IG43RPEJ1RI-xhXU2c=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7HAWW6AOHVDDHAP6YOVUXJJJYI.jpghttps://insights.citeline.com/pink-sheet/product-reviews/us-advisory-committees/us-fda-questions-clinical-meaningfulness-of-astrazenecas-truqap-benefit-in-prostate-cancer-2LZUF6CEJFCUTDAWOCSTITJR7Q/2026-04-28T22:58:54.948Zalways0.5Insightsen2026-04-28T22:58:54.948Zhttps://insights.citeline.com/resizer/qInV_NgM1c0rNrPWu2MnoeyoA6E=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WXHYEADSLBCFZK363XK3YRMMRU.jpghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/regeneron-seeks-eu-fast-track-review-for-hearing-loss-gene-therapy-following-swift-us-approval-UN4F3X4II5B5ZACGPPETLQ3FKE/2026-04-28T22:58:37.252Zalways0.5Insightsen2026-04-28T22:58:37.252Zhttps://insights.citeline.com/resizer/HfTwQSdqWzgoAxonbD6zUv6j8Fw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YSUOH3MUCVD6LMI4BTZ2KBZ4ME.jpghttps://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/us-fda-unveils-real-time-clinical-trials-to-speed-data-review-XPVE4IJAHJBVVMXRCLJH7ZHTIA/2026-04-28T22:57:40.402Zalways0.5Insightsen2026-04-28T22:57:40.402Zhttps://insights.citeline.com/resizer/0kA7rfHlsLZBeRrfLPrz_Ifk8vk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/AMML2JU7O5BGDBH3FUQCG4XNXA.jpghttps://insights.citeline.com/medtech-insight/business/financing/fred-moll-backed-squaremind-raises-18m-to-bring-full-body-imaging-to-dermatologists-in-eu-us-H6G3YAG2TJCNHO62JDM5CCNPUE/2026-04-28T22:20:02.555Zalways0.5Insightsen2026-04-28T22:20:02.555Zhttps://insights.citeline.com/resizer/avLSgY-QwfWl8y428kXbIJivDoU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/LLOSHKY23VBWZNAFALH7WACGMA.jpeghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/boehringer-reports-first-phase-iii-results-for-survodutide-in-obesity-but-is-it-enough-BYHZP2BDCBB3PMY5AC23MSIDTI/2026-04-28T22:02:17.612Zalways0.5Insightsen2026-04-28T22:02:17.612Zhttps://insights.citeline.com/resizer/jYuM0rM2LAdo9rsThjsfzRMp2Xo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JVHUDDUVGBAZJB7UKGDRCEYHCQ.jpghttps://insights.citeline.com/scrip/business/stock-watch/stock-watch-light-and-shade-for-sanofi-more-darkness-for-roche-ADW4BG74PVH27BSPS4MPIYG3ZM/2026-04-28T22:01:34.83Zalways0.5Insightsen2026-04-28T22:01:34.83Zhttps://insights.citeline.com/resizer/Qc3iPiVhyGTKTN-mIks-Uj1MF-g=/cloudfront-us-east-1.images.arcpublishing.com/norstella/Y4FNFQUS2NKHVAF5UBUXPCPX74.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/oruka-clears-the-skyrizi-bar-with-phase-ii-plaque-psoriasis-data-ULLC5B4Z35GGZFTXGNKT3PB2KE/2026-04-28T22:00:42.015Zalways0.5Insightsen2026-04-28T22:00:42.015Zhttps://insights.citeline.com/resizer/Owb4G_ZqiQdM4MqAqQKgMqU1zqQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IL5F7A2INVHS5AMI3TTQIWKWWU.jpghttps://insights.citeline.com/scrip/business/earnings/kisqali-and-pluvicto-help-soften-novartiss-patent-expiry-pain-ASSMPC7YLRDOXLPIQAGIRSU3JM/2026-04-28T22:00:14.207Zalways0.5Insightsen2026-04-28T22:00:14.207Zhttps://insights.citeline.com/resizer/2_AdUta3L4tiMUj8Ots2_nxc_zY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6P4T64EXLRDJHD3TKBS7KCERDQ.jpghttps://insights.citeline.com/scrip/business/start-ups-and-smes/investors-declare-revolution-the-winner-in-pan-ras-skirmish-with-erasca-OEONVHLHY5ANVJSMSHC33IYPB4/2026-04-28T21:59:39.721Zalways0.5Insightsen2026-04-28T21:59:39.721Zhttps://insights.citeline.com/resizer/-TkrAiB_vgKm2S41coL4c2LQERU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/LEKODUOQHFOUZC73IPAMT2DAQI.jpghttps://insights.citeline.com/scrip/drug-pricing/novartis-ceo-calls-for-complete-rethink-on-europe-pricing-LTL4JD7MJNE3TPOWT6WCTSBY6Q/2026-04-28T21:59:01.248Zalways0.5Insightsen2026-04-28T21:59:01.248Zhttps://insights.citeline.com/resizer/oh2I9hKzeSjmXwLV1C6kzLU2edo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZMBWL2VWVFJUVO5WLCM4VG3BCU.jpghttps://insights.citeline.com/scrip/business/financing/coultreon-raises-125m-to-take-lead-sik3-inhibitor-into-phase-ii-ZOVLXMHDEJGFHJPKQLF6IRVSZI/2026-04-28T21:58:36.975Zalways0.5Insightsen2026-04-28T21:58:36.975Zhttps://insights.citeline.com/resizer/IiDMUYc_MeGx9q7_yHnDhzFXe9c=/cloudfront-us-east-1.images.arcpublishing.com/norstella/TLZN4TCNRVEKDHH6SGLQPDH6KI.jpghttps://insights.citeline.com/scrip/advanced-therapies/gene-therapies/lilly-teams-up-with-profluent-in-ai-powered-gene-editing-pact-JXBI6RBFIVAIBBRNFK5EKLMORI/2026-04-28T21:58:15.719Zalways0.5Insightsen2026-04-28T21:58:15.719Zhttps://insights.citeline.com/resizer/OWdarYXuEUFyf_tgdaiagZjrDm0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/W72S7LJOVJA3FHHDIL3SCQCDMQ.jpghttps://insights.citeline.com/scrip/therapeutic-category/immunological/incyte-eyes-blockbuster-vitiligo-opportunity-with-povorcitinib-FQPR5H6LPZEFVCYMBSR3ZX7FEE/2026-04-28T21:57:46.465Zalways0.5Insightsen2026-04-28T21:57:46.465Zhttps://insights.citeline.com/resizer/hUJ5v4N_xKv8VeAAeHeXq1c0rII=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DHCB2KULONBZPBULH55NDCIXNE.jpghttps://insights.citeline.com/scrip/business/deals/abbvie-seeks-pan-kras-position-with-kestrel-financing-and-option-deal-FHQWCHNRDNC77HFMTIHEBDF53I/2026-04-28T21:57:19.913Zalways0.5Insightsen2026-04-28T21:57:19.913Zhttps://insights.citeline.com/resizer/LLPSGCCjqtrAxVva9i2kocGyIUs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BVIZTLIM6NKH5PKZLRC3W76S54.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/veradermics-vdphl01-makes-hair-and-the-companys-cash-balance-grow-X5CDIVE3GZHB7GZ6QTGM5V4FTM/2026-04-28T21:50:23.704Zalways0.5Insightsen2026-04-28T21:50:23.704Zhttps://insights.citeline.com/resizer/kkewf_h1GeILFKfXrkuwB16GnhI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NBJ3FNGVL5GMJDDZG3ZTBFANGM.jpghttps://insights.citeline.com/hbw-insight/beauty/business/earnings/loreal-ceo-global-beauty-consumption-unaffected-by-middle-east-conflict-so-far-YCDB4BM5TNB7VBEZDF3AKOQOAQ/2026-04-28T20:42:20.369Zalways0.5Insightsen2026-04-28T20:42:20.369Zhttps://insights.citeline.com/resizer/ceZc_jjD7xLfyGHNKfvY_YDPh0U=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CEQMHGA46NDIXGZZP47CVTJNLM.jpghttps://insights.citeline.com/medtech-insight/device-area/combination-products/fdas-device-center-zeroes-in-on-nitrosamine-contamination-risk-KV6XKFR45VCNDN5D73HN3W67YA/2026-04-28T20:11:47.744Zalways0.5Insightsen2026-04-28T20:11:47.744Zhttps://insights.citeline.com/resizer/5ZvGIMtlN0N1ELY5xoEAgE3jX-I=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JUOKD43PS5GLNASXCFYUXMXI5E.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/nokia-rides-the-ai-supercycle-wave-in-apac-YF7D3L77OZCC5K2GJJWITUE5WI/2026-04-28T19:57:50.184Zalways0.5Insightsen2026-04-28T19:57:50.184Zhttps://insights.citeline.com/resizer/_qRoXEB4LOUZd-fv2LUNiIhdRd0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SS3YAYJHDJESNK3F6TQMT76XXU.jpghttps://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-more-vc-mega-rounds-and-two-new-funds-to-close-out-2025-JXU7KSSVEVERJETU6GEVA2REQA/2026-04-28T19:32:36.134Zalways0.5Insightsen2026-04-28T19:32:36.134Zhttps://insights.citeline.com/resizer/cInTrHhf4lm96TCzMQLN0bLTTRI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SDNUC6JU3VLANCGYXXII3MD4RM.jpghttps://insights.citeline.com/medtech-insight/business/strategy/indian-medtech-welcomes-india-nz-fta-but-calls-cdsco-exclusion-a-strategic-gap-C72BP7WBMFAS7I534KKDDBZFIA/2026-04-28T18:35:44.648Zalways0.5Insightsen2026-04-28T18:35:44.648Zhttps://insights.citeline.com/resizer/3-eyrzHhCGfeqGSFzI3A9A0oIJ8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UX4PUDERU5D2BPQQKORTS4DSRI.jpghttps://insights.citeline.com/medtech-insight/digital-technologies/ai/thinktrends-agentic-ai-goes-live-at-fda-processing-adverse-event-reports-at-scale-E7LUBK4MBFHUBEFXZ5MJCJYKFA/2026-04-28T18:29:46.427Zalways0.5Insightsen2026-04-28T18:29:46.427Zhttps://insights.citeline.com/resizer/Sa7EaFw65aE5LGN7Yv_qRlFeZTQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KIRFJWT66VGQRF6I5LQSQGT6KM.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/fresh-off-its-launch-novartiss-rhapsido-notches-phase-iii-win-in-chronic-inducible-urticaria-T2KCMKQL5FEMLP53E6WB5L4L4E/2026-04-28T17:30:30.829Zalways0.5Insightsen2026-04-28T17:30:30.829Zhttps://insights.citeline.com/resizer/bgWEvfMQuyTbwluA26Va8A2Iulo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3QOCDSZO5NGQJIDOW32XSC56F4.jpghttps://insights.citeline.com/scrip/leadership/interviews/novartis-forges-ahead-with-rhapsido-for-food-allergy-QHRN7U2U5RBMFEOAUU7SHCGS6A/2026-04-28T17:29:13.413Zalways0.5Insightsen2026-04-28T17:29:13.413Zhttps://insights.citeline.com/resizer/Yzp6z8DUVn37zURU95TH1m-H0Rk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/R3XYBDPUL5NELEX5MW5NFAU7OI.jpghttps://insights.citeline.com/scrip/conferences/jp-morgan/argenx-is-a-standout-in-biotech-can-its-high-powered-growth-continue-Z6WJBBOFWZB5DCTGRO7O6ILSPU/2026-04-28T16:46:59.76Zalways0.5Insightsen2026-04-28T16:46:59.76Zhttps://insights.citeline.com/resizer/Hydt6O5dP3ZZmN1eDXlkKCVqe8o=/cloudfront-us-east-1.images.arcpublishing.com/norstella/VDVI6PIXAVGVJPZSNHF4KUZICA.jpghttps://insights.citeline.com/hbw-insight/health/business/deals/church-dwight-partners-with-stada-to-enter-eurasia-4UZEZLUHD5GYRH6GS5W5FJND6U/2026-04-28T16:44:55.853Zalways0.5Insightsen2026-04-28T16:44:55.853Zhttps://insights.citeline.com/resizer/eFOFaipYE1vfJiQHrZ_f8OHeGH0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/OQ7PXOXHWZFZBC5RMCKHH7U3VA.jpghttps://insights.citeline.com/scrip/business/strategy/amgens-rare-disease-portfolio-grows-with-second-approved-uplizna-indication-7NFWYQ2LPFGERHNKX44XA2BDW4/2026-04-28T16:42:22.956Zalways0.5Insightsen2026-04-28T16:42:22.956Zhttps://insights.citeline.com/resizer/mNWwfPgPLG8lObHyPXOc6j2ft54=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4STM6ZZXDBCDLNNRFXCSGTD6YI.jpghttps://insights.citeline.com/scrip/rare-diseases/amgens-uplizna-approved-for-its-largest-and-most-competitive-indication-yet-5JF4NDSRZJDT3PPUNI337CKLNY/2026-04-28T16:40:49.484Zalways0.5Insightsen2026-04-28T16:40:49.484Zhttps://insights.citeline.com/resizer/ffsDEgg0avinhG1dKBraKEaTods=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ODA36K77UNCS3BCZE4O6ATTRZU.jpghttps://insights.citeline.com/scrip/therapeutic-category/immunological/why-viridian-wants-in-on-fcrns-despite-being-late-to-the-game-V6EVRZKGBJCCHGBCIUBCPR2N3A/2026-04-28T16:38:38.105Zalways0.5Insightsen2026-04-28T16:38:38.105Zhttps://insights.citeline.com/resizer/uXXGs90ONFywxfn0AbFuds6PlU4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/26JMYZ5IJVFYVPZV75AREJ6Q2A.jpghttps://insights.citeline.com/medtech-insight/device-area/cardiology/medtronic-catheter-shows-promise-in-treating-dangerous-heart-disorder-2NIWG5TW5NBSDABOUN7G777274/2026-04-28T16:21:32.722Zalways0.5Insightsen2026-04-28T16:21:32.722Zhttps://insights.citeline.com/resizer/DF0R_CSheagktm5U8GldKz_IAAo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/APLIWGDE7FFFND5SL2URYTD6TM.jpghttps://insights.citeline.com/generics-bulletin/products/generics/gdufa-iv-talks-reach-tentative-agreement-america-first-application-fee-waiver-added-CO5ABY4CIJGUBJF7QXIQ4HMHDM/2026-04-28T15:51:53.149Zalways0.5Insightsen2026-04-28T15:51:53.149Zhttps://insights.citeline.com/resizer/q2DP6SqWe5SEdhZy-K0jW-uI7FU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5KL7IOS5TFFSHNDICC6VFJGCFM.jpghttps://insights.citeline.com/generics-bulletin/policy-and-regulation/regulation/off-patent-firms-appeal-eu-courts-ruling-on-the-individual-impact-of-uwwtd-D7JETA3HVBH5VECZXF2JWLUJJU/2026-04-28T13:46:02.811Zalways0.5Insightsen2026-04-28T13:46:02.811Zhttps://insights.citeline.com/resizer/XFegZ07zLl-9faReOb04008v8x4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/FB4AHO3WEZF35MCCJWTSTMTLFI.jpghttps://insights.citeline.com/generics-bulletin/business/deals/lenacapavir-rollout-builds-toward-pivotal-2027-generics-shift-SNCTB2FZJ5FJXFI3O2CHWIR43U/2026-04-28T13:11:37.011Zalways0.5Insightsen2026-04-28T13:11:37.011Zhttps://insights.citeline.com/resizer/RNLCfXfWbSdNuEf7M2wS8aPml4I=/cloudfront-us-east-1.images.arcpublishing.com/norstella/MKJCQUQYTFAGFKWIIUT5J3SPNQ.jpghttps://insights.citeline.com/generics-bulletin/business/strategy/canadas-apotex-makes-bold-us-move-with-cumberland-pharmaceuticals-deal-A7OTZNFHNZANXJFZL3CSW43Y2E/2026-04-28T13:02:03.597Zalways0.5Insightsen2026-04-28T13:02:03.597Zhttps://insights.citeline.com/resizer/WiVW9lKaZ57q8kHVcN9USst8x8w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/I2F2WITV5ZCP3NKO3CV6HZFLDE.jpghttps://insights.citeline.com/pink-sheet/regulatory-trackers/european-performance-tracker/eu-chmp-opinions-and-maa-updates2026-04-28T12:01:16.483Zalways0.5Insightsen2026-04-28T12:01:16.483Zhttps://insights.citeline.com/SC142954/Gilead-Buys-Pipeline-In-A-Product-With-$21bn-Immunomedics-Deal/2026-04-28T11:33:34.938Zalways0.5Insightsen2026-04-28T11:33:34.938Zhttps://insights.citeline.com/resizer/uEwvbPtKKJrPuehh8rfyCCQXOI0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KMW4PS53BNKYNOEFYKBF3LRH3Y.jpghttps://insights.citeline.com/SC147871/Pipeline-In-A-Product-Nipocalimab-Starts-Delivering-For-JJ/2026-04-28T11:32:52.481Zalways0.5Insightsen2026-04-28T11:32:52.481Zhttps://insights.citeline.com/resizer/KmaIR_ydyoaHVQAoEM-ZGTDzPYw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/R6YSYVPOXNJCNFYSDL4TVYHHLE.jpghttps://insights.citeline.com/scrip/new-products/jjs-imaavy-approval-is-the-starting-line-for-pipeline-in-a-product-strategy-N6W5EFTACVBQXMKWDHT34ANNSE/2026-04-28T11:31:53.422Zalways0.5Insightsen2026-04-28T11:31:53.422Zhttps://insights.citeline.com/resizer/ymezvse9R6HmvlZ9hsa6CmswOmM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/J7GOD5PXHVCGRDCAX6MT6ZCAGE.jpghttps://insights.citeline.com/scrip/business/strategy/novartiss-pipeline-in-a-product-assets-progressing-well-FSIZI4WCCZAVXL7W5ZWSE5HNBM/2026-04-28T11:30:32.591Zalways0.5Insightsen2026-04-28T11:30:32.591Zhttps://insights.citeline.com/resizer/Bgi-R04Vjdg0UXYj7hHbHjbByAE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/23UGRPPE2VHW5BXCRFDHEQQFOE.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/sjogrens-success-for-ianalumab-shores-up-novartiss-pipeline-in-a-product-plans-6RYHNKMJMVHDVMJOSFOBDK2HMU/2026-04-28T11:29:37.758Zalways0.5Insightsen2026-04-28T11:29:37.758Zhttps://insights.citeline.com/resizer/O880EWPmGpZ1Bnq3d7pjEluZWKI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7YFBZL3JPFNGLCOY426T3VXKQQ.jpghttps://insights.citeline.com/scrip/business/pipeline-in-a-product-a-retrospective-on-the-development-of-dupixent-25CRQLKVRVGUFFWZUEFDQNXXLQ/2026-04-28T11:28:37.003Zalways0.5Insightsen2026-04-28T11:28:37.003Zhttps://insights.citeline.com/resizer/t7ArYrx2xeyFFRVoT9RJ5IvjFss=/cloudfront-us-east-1.images.arcpublishing.com/norstella/URP2V6XSZNBPDNA4GD6CRDDKWY.jpghttps://insights.citeline.com/scrip/business/strategy/novartis-pipeline-in-a-product-remibrutinib-secures-first-approval-O6NEZ7WCSFGRRFA4LXPN6Y5LOI/2026-04-28T11:27:11.175Zalways0.5Insightsen2026-04-28T11:27:11.175Zhttps://insights.citeline.com/resizer/DDHb_8QhBGdKBkRS9e61rHuck7k=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IUEDNWJ43BBZBCA6DAUR56DWUE.jpghttps://insights.citeline.com/scrip/therapeutic-category/immunological/merck-expands-tulisokibart-development-in-pipeline-in-a-product-race-RV7HT3ZXZ5BPJHMHG76VKSE5CE/2026-04-28T11:26:14.592Zalways0.5Insightsen2026-04-28T11:26:14.592Zhttps://insights.citeline.com/resizer/kHAbz02IUrTyltLeOL7KAz4M_Js=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XWOFM44EBRCZNE6SITIHI2E5XY.jpghttps://insights.citeline.com/scrip/business/strategy/ucbs-bold-plans-for-pipeline-in-a-product-bimzelx-are-paying-off-NH3FXPQLZJAM3H26B3FQ4D7PWM/2026-04-28T11:25:35.226Zalways0.5Insightsen2026-04-28T11:25:35.226Zhttps://insights.citeline.com/resizer/CSym7oJKOqCAT-CFRI3_QV42ACo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KSPJX5UIFRBEJAPMHNFHN37Y64.jpghttps://insights.citeline.com/scrip/therapeutic-category/immunological/fcrn-inhibitors-a-promising-pipeline-in-a-product-frontier-32GTAILE5RGBFPYRLSQEQA3OO4/2026-04-28T11:23:43.262Zalways0.5Insightsen2026-04-28T11:23:43.262Zhttps://insights.citeline.com/resizer/apmg2YNC689adHZtSeUcOBjBV18=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GLW7VQMM3ZFCNLL2KJ3YS33Y3M.jpghttps://insights.citeline.com/generics-bulletin/business/deals/kyorin-joins-daito-plan-to-stabilize-japanese-generics-FCOHZII2OVDS5GUXB6FNW3W5ZQ/2026-04-28T10:34:47.881Zalways0.5Insightsen2026-04-28T10:34:47.881Zhttps://insights.citeline.com/resizer/LlFFj55fY9dFyEaOCBfFBl0yOJY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UNQ43U3XJBHMXLSHNZYQAWKHNE.jpghttps://insights.citeline.com/in-vivo/podcasts/podcast-genyros-adrian-woolfson-on-artificial-biological-intelligence-and-genome-writing-6XKUKNW2PVCIRBW5U7RXBQJSLQ/2026-04-28T09:58:26.398Zalways0.5Insightsen2026-04-28T09:58:26.398Zhttps://insights.citeline.com/resizer/ZRS16ILQ0j4uuhBNksV741SfUWI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/I775OILYCVCTFNEIV7IFDNKQQI.pnghttps://insights.citeline.com/scrip/r-and-d/canwell-advances-first-her2-targeting-dual-cytotoxic-payload-adc-into-phase-i-PK3OCFAORJDIBDKYPIGW53NIVA/2026-04-28T08:41:05.432Zalways0.5Insightsen2026-04-28T08:41:05.432Zhttps://insights.citeline.com/resizer/d9-KpFuPMnkWvtbc4JcIwIjEONE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XE2B7D3MM5H4ZOME66E5VBXAHI.jpghttps://insights.citeline.com/scrip/business/deals/beone-obtains-global-rights-to-huahui-healths-trispecifics-for-up-to-153bn-YQ3GT3USL5A27EYPP3BXIGX4EM/2026-04-28T08:39:47.702Zalways0.5Insightsen2026-04-28T08:39:47.702Zhttps://insights.citeline.com/resizer/PL_J5dUEyUkhifKkZXEjn3HstfA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DC2L3OSIRRD7XJF3TZK3GPX7LA.jpghttps://insights.citeline.com/hbw-insight/podcasts/over-the-counter-cracking-chinas-consumer-health-market-with-qiva-globals-ellie-adams-YC2SZDOAWFFH7KA2D4CNFAF2XY/2026-04-28T08:19:46.004Zalways0.5Insightsen2026-04-28T08:19:46.004Zhttps://insights.citeline.com/resizer/kzpGPHP5SF9Z0UhgVPskCH4I1zY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/AU44X4X4GZHWHE5TQHL3X4YVGU.jpghttps://insights.citeline.com/medtech-insight/raps-2026-preview-eu-medtech-regulation-at-a-crossroads-FULY6FCUKRFQHKDE2QR7JE4AIA/2026-04-28T08:07:54.847Zalways0.5Insightsen2026-04-28T08:07:54.847Zhttps://insights.citeline.com/resizer/1k-KZn0oQ-VMWFr5q5xTu03D-kw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KWDI55KK5BGJHIKNZJXLVAQP4U.jpghttps://insights.citeline.com/scrip/focus-on-asia/india/sun-makes-bold-bet-with-1175bn-organon-deal-BBMJC3F55ZC3TIV2RSS5QZDOOI/2026-04-28T06:21:29.458Zalways0.5Insightsen2026-04-28T06:21:29.458Zhttps://insights.citeline.com/resizer/5-RMVDCbwNiU1zYDXozPRR3FVLE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/B4V2YNYG45CU5IZCKHEJZOROII.jpghttps://insights.citeline.com/scrip/focus-on-asia/india/debt-to-scale-shanghvis-bold-organon-deal-signals-a-new-sun-is-rising-UPZ7FBVOPVBTJL3GY7OOKYWXOA/2026-04-28T04:59:38.553Zalways0.5Insightsen2026-04-28T04:59:38.553Zhttps://insights.citeline.com/resizer/ZYLIw0Ui2IR5kNMdo5IJl1YJuYo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YMUQ2YP555HT5MFPA7LIDKUKAQ.jpghttps://insights.citeline.com/hbw-insight/health/rx-to-otc-switch/history-lesson-on-establishing-two-drug-classes-opens-look-at-future-of-otc-access-in-us-ADIKZCCLRZDMVL7RN4USMJUW34/2026-04-28T03:39:27.49Zalways0.5Insightsen2026-04-28T03:39:27.49Zhttps://insights.citeline.com/resizer/d1EVI6BnhW51L2ajp7wfRMG6oyQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IOM6P77NSVHSPEVQZWQ2W3HCUM.jpghttps://insights.citeline.com/hbw-insight/health/rx-to-otc-switch/with-low-hanging-fruit-of-conventional-otc-switches-picked-clean-acnu-seeds-new-us-crop-VK2M3J3YBBDTVIKVZE662JH4YA/2026-04-28T03:35:41.789Zalways0.5Insightsen2026-04-28T03:35:41.789Zhttps://insights.citeline.com/resizer/IvvbTjomH0adilRvDH636ZIn4PU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JTZGYD7RPFFC7IQQY6KZYMY2AI.jpghttps://insights.citeline.com/scrip/business/deals/eli-lilly-goes-from-backer-to-buyer-with-ajax-deal-JLJZAXEUOJFYPDKT3Q2ZSKJJNE/2026-04-28T01:10:59.174Zalways0.5Insightsen2026-04-28T01:10:59.174Zhttps://insights.citeline.com/resizer/Tv1vcBRo_sbt6d7GGlsz4tyb1iM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CN7RA4TYANDVHEHIVZ4II24N4E.jpeghttps://insights.citeline.com/scrip/leadership/outgoing-santhera-ceo-reflects-on-firms-remarkable-recovery-W5J6J5U4IVHWHLV5KLTG4QAWBY/2026-04-28T01:09:35.025Zalways0.5Insightsen2026-04-28T01:09:35.025Zhttps://insights.citeline.com/resizer/FE3FP8A_Rt5QU_dnZejua_2T6Zo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JWO74FF2QBKWVHBVWRCEBW24KY.jpghttps://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-sage-executives-return-with-a-new-neurology-start-up-6P5KVEMSMFEPFCBTFSZLEIZAJU/2026-04-28T01:08:21.549Zalways0.5Insightsen2026-04-28T01:08:21.549Zhttps://insights.citeline.com/resizer/cInTrHhf4lm96TCzMQLN0bLTTRI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SDNUC6JU3VLANCGYXXII3MD4RM.jpghttps://insights.citeline.com/scrip/therapeutic-category/anticancer/compass-shows-pfs-benefit-for-tovecimig-with-confounding-os-result-GIWUL6FWAZH7LGEXSPEARIN2LA/2026-04-28T01:07:28.41Zalways0.5Insightsen2026-04-28T01:07:28.41Zhttps://insights.citeline.com/scrip/advanced-therapies/gene-therapies/intellia-heads-to-fda-with-positive-phase-iii-results-for-lonvo-z-YHSADVCPAVAQDOPOHEX2UXFQH4/2026-04-28T01:07:22.655Zalways0.5Insightsen2026-04-28T01:07:22.655Zhttps://insights.citeline.com/resizer/SI4x5dm-b906Kp0Mvmq8wcxZwGE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/46U76MQRC5CYRLW44QCPURM3SU.jpghttps://insights.citeline.com/scrip/business/deals/proposed-ligandxoma-merger-would-create-third-biggest-royalty-aggregator-EUXVOQNXJ5FTVCRBE57JWPRXW4/2026-04-28T01:06:55.943Zalways0.5Insightsen2026-04-28T01:06:55.943Zhttps://insights.citeline.com/resizer/1i4H-ULfEWPlFvoswaJSqOyRzIk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BMNDBBPE2ZMENLSPUQCHSARSKQ.jpghttps://insights.citeline.com/companies/shaanxi-huikang-biotech-co-ltd/2026-04-28T00:09:43.53Zalways0.5Insightsen2026-04-28T00:09:43.53Zhttps://insights.citeline.com/companies/alpha-cog/2026-04-28T00:09:39.643Zalways0.5Insightsen2026-04-28T00:09:39.643Zhttps://insights.citeline.com/companies/miracell-co-ltd/2026-04-28T00:09:35.582Zalways0.5Insightsen2026-04-28T00:09:35.582Zhttps://insights.citeline.com/companies/coachrom-diagnostica-gmbh/2026-04-28T00:09:31.658Zalways0.5Insightsen2026-04-28T00:09:31.658Zhttps://insights.citeline.com/companies/stgen-bio-co-ltd/2026-04-28T00:09:27.592Zalways0.5Insightsen2026-04-28T00:09:27.592Zhttps://insights.citeline.com/companies/vifor-fresenius-medical-care-renal-pharma/2026-04-28T00:09:23.418Zalways0.5Insightsen2026-04-28T00:09:23.418Zhttps://insights.citeline.com/companies/ferrosa-therapeutics-ag/2026-04-28T00:09:19.556Zalways0.5Insightsen2026-04-28T00:09:19.556Zhttps://insights.citeline.com/companies/legacy-pharma-inc-sezc/2026-04-28T00:09:15.501Zalways0.5Insightsen2026-04-28T00:09:15.501Zhttps://insights.citeline.com/companies/alcedis-gmbh2026-04-28T00:09:11.443Zalways0.5Insightsen2026-04-28T00:09:11.443Zhttps://insights.citeline.com/companies/reacx-pharmaceuticals-inc2026-04-28T00:09:07.669Zalways0.5Insightsen2026-04-28T00:09:07.669Zhttps://insights.citeline.com/companies/shanghai-caizhi-yaocheng-biotechnology2026-04-28T00:09:03.533Zalways0.5Insightsen2026-04-28T00:09:03.533Zhttps://insights.citeline.com/companies/celerion2026-04-28T00:08:59.351Zalways0.5Insightsen2026-04-28T00:08:59.351Zhttps://insights.citeline.com/companies/guangzhou-aqixi-new-drug-research/2026-04-28T00:08:55.481Zalways0.5Insightsen2026-04-28T00:08:55.481Zhttps://insights.citeline.com/companies/renaissance-pharma-ltd2026-04-28T00:08:47.371Zalways0.5Insightsen2026-04-28T00:08:47.371Zhttps://insights.citeline.com/companies/whitehead-institute2026-04-28T00:08:43.214Zalways0.5Insightsen2026-04-28T00:08:43.214Zhttps://insights.citeline.com/companies/genecast-biotechnology-co-ltd2026-04-28T00:08:39.194Zalways0.5Insightsen2026-04-28T00:08:39.194Zhttps://insights.citeline.com/companies/transcend-therapeutics2026-04-28T00:08:35.224Zalways0.5Insightsen2026-04-28T00:08:35.224Zhttps://insights.citeline.com/companies/amplitude-vascular-systems-avs2026-04-28T00:08:31.226Zalways0.5Insightsen2026-04-28T00:08:31.226Zhttps://insights.citeline.com/companies/virtue-diagnostics-suzhou-coltd2026-04-28T00:08:27.121Zalways0.5Insightsen2026-04-28T00:08:27.121Zhttps://insights.citeline.com/companies/kelonia-therapeutics-inc2026-04-28T00:08:23.143Zalways0.5Insightsen2026-04-28T00:08:23.143Zhttps://insights.citeline.com/companies/evariste2026-04-28T00:08:19.065Zalways0.5Insightsen2026-04-28T00:08:19.065Zhttps://insights.citeline.com/companies/duke-university2026-04-28T00:08:15.145Zalways0.5Insightsen2026-04-28T00:08:15.145Zhttps://insights.citeline.com/companies/seer-inc2026-04-28T00:08:10.878Zalways0.5Insightsen2026-04-28T00:08:10.878Zhttps://insights.citeline.com/companies/neurona-therapeutics-inc2026-04-28T00:08:07.014Zalways0.5Insightsen2026-04-28T00:08:07.014Zhttps://insights.citeline.com/companies/icahn-school-of-medicine2026-04-28T00:08:02.988Zalways0.5Insightsen2026-04-28T00:08:02.988Zhttps://insights.citeline.com/companies/day-one-biopharmaceuticals-inc/2026-04-28T00:07:58.865Zalways0.5Insightsen2026-04-28T00:07:58.865Zhttps://insights.citeline.com/companies/university-of-western-ontario2026-04-28T00:07:55.372Zalways0.5Insightsen2026-04-28T00:07:55.372Zhttps://insights.citeline.com/companies/guangzhou-institutes-of-biomedicine-and-health2026-04-28T00:07:51.1Zalways0.5Insightsen2026-04-28T00:07:51.1Zhttps://insights.citeline.com/companies/tianhe-stem-cell-biotechnologies-inc2026-04-28T00:07:46.897Zalways0.5Insightsen2026-04-28T00:07:46.897Zhttps://insights.citeline.com/companies/konkuk-university2026-04-28T00:07:42.722Zalways0.5Insightsen2026-04-28T00:07:42.722Zhttps://insights.citeline.com/companies/barth-syndrome-foundation2026-04-28T00:07:39.024Zalways0.5Insightsen2026-04-28T00:07:39.024Zhttps://insights.citeline.com/companies/singlomics-biopharmaceuticals2026-04-28T00:07:34.659Zalways0.5Insightsen2026-04-28T00:07:34.659Zhttps://insights.citeline.com/companies/exeltis-healthcare-sl2026-04-28T00:07:30.662Zalways0.5Insightsen2026-04-28T00:07:30.662Zhttps://insights.citeline.com/companies/tubulis-gmbh2026-04-28T00:07:26.695Zalways0.5Insightsen2026-04-28T00:07:26.695Zhttps://insights.citeline.com/companies/allwin-medical-devices-inc/2026-04-28T00:07:22.766Zalways0.5Insightsen2026-04-28T00:07:22.766Zhttps://insights.citeline.com/companies/gansu-longshenrongfa-pharmaceutical-industry-co-ltd2026-04-28T00:07:18.541Zalways0.5Insightsen2026-04-28T00:07:18.541Zhttps://insights.citeline.com/companies/hexagon-bio-inc2026-04-28T00:07:14.541Zalways0.5Insightsen2026-04-28T00:07:14.541Zhttps://insights.citeline.com/companies/boston-medical-center2026-04-28T00:07:10.821Zalways0.5Insightsen2026-04-28T00:07:10.821Zhttps://insights.citeline.com/companies/hubrecht-organoid-technology2026-04-28T00:07:06.579Zalways0.5Insightsen2026-04-28T00:07:06.579Zhttps://insights.citeline.com/companies/international-flavors-fragrances2026-04-28T00:07:01.561Zalways0.5Insightsen2026-04-28T00:07:01.561Zhttps://insights.citeline.com/companies/vor-biopharma-inc2026-04-28T00:06:55.556Zalways0.5Insightsen2026-04-28T00:06:55.556Zhttps://insights.citeline.com/companies/dnanexus-inc2026-04-28T00:06:49.367Zalways0.5Insightsen2026-04-28T00:06:49.367Zhttps://insights.citeline.com/companies/la-jolla-institute-for-immunology2026-04-28T00:06:43.603Zalways0.5Insightsen2026-04-28T00:06:43.603Zhttps://insights.citeline.com/companies/southern-illinois-university2026-04-28T00:06:37.646Zalways0.5Insightsen2026-04-28T00:06:37.646Zhttps://insights.citeline.com/companies/dalhousie-university2026-04-28T00:06:31.421Zalways0.5Insightsen2026-04-28T00:06:31.421Zhttps://insights.citeline.com/companies/the-research-foundation-for-the-state-university-of-new-york2026-04-28T00:06:25.604Zalways0.5Insightsen2026-04-28T00:06:25.604Zhttps://insights.citeline.com/companies/baker-heart-diabetes-institute2026-04-28T00:06:19.266Zalways0.5Insightsen2026-04-28T00:06:19.266Zhttps://insights.citeline.com/companies/university-of-hamburg2026-04-28T00:06:13.559Zalways0.5Insightsen2026-04-28T00:06:13.559Zhttps://insights.citeline.com/companies/university-of-cologne2026-04-28T00:06:07.268Zalways0.5Insightsen2026-04-28T00:06:07.268Zhttps://insights.citeline.com/companies/university-of-california-irvine2026-04-28T00:06:01.585Zalways0.5Insightsen2026-04-28T00:06:01.585Zhttps://insights.citeline.com/companies/university-of-ferrara2026-04-28T00:05:55.222Zalways0.5Insightsen2026-04-28T00:05:55.222Zhttps://insights.citeline.com/companies/vrije-university2026-04-28T00:05:49.129Zalways0.5Insightsen2026-04-28T00:05:49.129Zhttps://insights.citeline.com/companies/lifeliver-co-ltd2026-04-28T00:05:43.342Zalways0.5Insightsen2026-04-28T00:05:43.342Zhttps://insights.citeline.com/companies/cleveland-clinic2026-04-28T00:05:36.984Zalways0.5Insightsen2026-04-28T00:05:36.984Zhttps://insights.citeline.com/companies/brandeis-university2026-04-28T00:05:31.19Zalways0.5Insightsen2026-04-28T00:05:31.19Zhttps://insights.citeline.com/companies/dartmouth-college2026-04-28T00:05:25.02Zalways0.5Insightsen2026-04-28T00:05:25.02Zhttps://insights.citeline.com/companies/organon2026-04-28T00:05:19.115Zalways0.5Insightsen2026-04-28T00:05:19.115Zhttps://insights.citeline.com/companies/albert-einstein-college-of-medicine2026-04-28T00:05:12.955Zalways0.5Insightsen2026-04-28T00:05:12.955Zhttps://insights.citeline.com/companies/boston-childrens-hospital2026-04-28T00:05:00.913Zalways0.5Insightsen2026-04-28T00:05:00.913Zhttps://insights.citeline.com/companies/vib2026-04-28T00:04:54.998Zalways0.5Insightsen2026-04-28T00:04:54.998Zhttps://insights.citeline.com/companies/onconano-medicine-inc2026-04-28T00:04:48.776Zalways0.5Insightsen2026-04-28T00:04:48.776Zhttps://insights.citeline.com/companies/obsidian-therapeutics-inc2026-04-28T00:04:42.696Zalways0.5Insightsen2026-04-28T00:04:42.696Zhttps://insights.citeline.com/companies/instituto-butantan2026-04-28T00:04:36.772Zalways0.5Insightsen2026-04-28T00:04:36.772Zhttps://insights.citeline.com/companies/immunogenx-inc2026-04-28T00:04:30.693Zalways0.5Insightsen2026-04-28T00:04:30.693Zhttps://insights.citeline.com/companies/huons-co-ltd2026-04-28T00:04:24.785Zalways0.5Insightsen2026-04-28T00:04:24.785Zhttps://insights.citeline.com/companies/tivic-health-systems-inc2026-04-28T00:04:18.676Zalways0.5Insightsen2026-04-28T00:04:18.676Zhttps://insights.citeline.com/companies/terns-pharmaceuticals-inc2026-04-28T00:04:13.778Zalways0.5Insightsen2026-04-28T00:04:13.778Zhttps://insights.citeline.com/companies/berlin-cures-holding-ag2026-04-28T00:04:06.644Zalways0.5Insightsen2026-04-28T00:04:06.644Zhttps://insights.citeline.com/companies/stimlabs-llc/2026-04-28T00:04:00.459Zalways0.5Insightsen2026-04-28T00:04:00.459Zhttps://insights.citeline.com/companies/biomx-inc2026-04-28T00:03:54.646Zalways0.5Insightsen2026-04-28T00:03:54.646Zhttps://insights.citeline.com/companies/cedars-sinai-medical-center2026-04-28T00:03:48.577Zalways0.5Insightsen2026-04-28T00:03:48.577Zhttps://insights.citeline.com/companies/the-german-cancer-research-center2026-04-28T00:03:42.667Zalways0.5Insightsen2026-04-28T00:03:42.667Zhttps://insights.citeline.com/companies/caredx-inc2026-04-28T00:03:36.51Zalways0.5Insightsen2026-04-28T00:03:36.51Zhttps://insights.citeline.com/companies/bioporto-diagnostics-as2026-04-28T00:03:30.401Zalways0.5Insightsen2026-04-28T00:03:30.401Zhttps://insights.citeline.com/companies/chemomab-therapeutics-ltd2026-04-28T00:03:24.407Zalways0.5Insightsen2026-04-28T00:03:24.407Zhttps://insights.citeline.com/companies/servier/2026-04-28T00:03:18.574Zalways0.5Insightsen2026-04-28T00:03:18.574Zhttps://insights.citeline.com/companies/soleno-therapeutics-inc2026-04-28T00:03:12.409Zalways0.5Insightsen2026-04-28T00:03:12.409Zhttps://insights.citeline.com/companies/anaptysbio-inc2026-04-28T00:03:06.349Zalways0.5Insightsen2026-04-28T00:03:06.349Zhttps://insights.citeline.com/companies/stereotaxis-inc2026-04-28T00:03:00.304Zalways0.5Insightsen2026-04-28T00:03:00.304Zhttps://insights.citeline.com/companies/gsk-plc2026-04-28T00:02:54.262Zalways0.5Insightsen2026-04-28T00:02:54.262Zhttps://insights.citeline.com/companies/california-institute-for-regenerative-medicine2026-04-28T00:02:48.131Zalways0.5Insightsen2026-04-28T00:02:48.131Zhttps://insights.citeline.com/companies/novartis-ag2026-04-28T00:02:42.993Zalways0.5Insightsen2026-04-28T00:02:42.993Zhttps://insights.citeline.com/companies/merck-co-inc2026-04-28T00:02:35.929Zalways0.5Insightsen2026-04-28T00:02:35.929Zhttps://insights.citeline.com/companies/fourth-military-medical-university2026-04-28T00:02:30.026Zalways0.5Insightsen2026-04-28T00:02:30.026Zhttps://insights.citeline.com/companies/pepgen-inc2026-04-28T00:02:23.966Zalways0.5Insightsen2026-04-28T00:02:23.966Zhttps://insights.citeline.com/companies/karolinska-institutet2026-04-28T00:02:17.994Zalways0.5Insightsen2026-04-28T00:02:17.994Zhttps://insights.citeline.com/companies/kintara-therapeutics2026-04-28T00:02:12.092Zalways0.5Insightsen2026-04-28T00:02:12.092Zhttps://insights.citeline.com/companies/university-of-tokyo2026-04-28T00:02:05.907Zalways0.5Insightsen2026-04-28T00:02:05.907Zhttps://insights.citeline.com/companies/galera-therapeutics-inc2026-04-28T00:01:56.986Zalways0.5Insightsen2026-04-28T00:01:56.986Zhttps://insights.citeline.com/companies/sun-pharmaceutical-industries-ltd2026-04-28T00:01:44.966Zalways0.5Insightsen2026-04-28T00:01:44.966Zhttps://insights.citeline.com/companies/dong-a-socio-holdings2026-04-28T00:01:33.248Zalways0.5Insightsen2026-04-28T00:01:33.248Zhttps://insights.citeline.com/companies/ucb-sa2026-04-28T00:01:21.139Zalways0.5Insightsen2026-04-28T00:01:21.139Z